Developing technology to monitor neurotransmitters in the retina
Biosensors for Determination of Multiple Neurotransmitters in Vertebrate Retina
This study is testing a new technology that can measure different brain chemicals in the eye at the same time, which could help us understand and treat eye diseases like diabetic retinopathy better.
Quick facts
| Grant type | R21 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Missouri-Columbia NIH-funded |
| Lab location | 1 site (Columbia, United States) |
| Project ID | NIH-11116684 on NIH RePORTER |
What this research studies
This research aims to create a new technology that can directly and simultaneously measure the activity of multiple neurotransmitters in the retina, which is crucial for understanding brain function and eye diseases. The retina is chosen as the model system due to its accessibility and established neurophysiology. By monitoring neurotransmitters like dopamine, GABA, and acetylcholine, researchers hope to gain insights into their roles in conditions such as diabetic retinopathy. This innovative approach could lead to better understanding and treatment of various eye disorders.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals suffering from eye diseases, particularly those related to neurotransmitter dysfunction, such as diabetic retinopathy.
Not a fit: Patients with eye conditions not related to neurotransmitter activity or those without retinal diseases may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved diagnostic tools and treatments for eye diseases linked to neurotransmitter imbalances.
How similar studies have performed: While the approach of monitoring neurotransmitters in the retina is innovative, similar technologies have shown promise in other areas of neuroscience, indicating potential for success.
Where this research is happening
Columbia, United States
- University of Missouri-Columbia — Columbia, United States (Active)
Researchers
- Principal investigator: Zeng, Xiangqun — University of Missouri-Columbia
- Study coordinator: Zeng, Xiangqun
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.